FDA Gets Senate Funding, House Scolding In FY 2015 CR-Omnibus
This article was originally published in The Pink Sheet Daily
Spending agreement would give FDA about a 1.3% increase from the fiscal year 2014 enacted appropriations legislation.
You may also be interested in...
FDA expects few people would get the disease in the U.S., but many could receive a vaccine.
Draft guidance on abuse-deterrent opioids notes that labeling claims may be revised if abusers outwit the abuse-resistant technology; the agency’s evaluation of generic-related citizen petitions continues.
The system likely will evolve as the post-pandemic world unfolds, but adds to the list of agency programs expecting to continue using virtual platforms once in-person activities are no longer restricted by COVID-19.